If you are looking to invest in Resverlogix Corp’s (TSX:RVX), or currently own the stock, then you need to understand its beta in order to understand how it can affect the risk of your portfolio. The ...
MUNICH and CALGARY, Aug. 28, 2012 /PRNewswire/ - Resverlogix Corp. (TSX: RVX) today announced that the BET protein inhibitor RVX-208 significantly increased HDL-C (p=0.001), the primary endpoint of ...
Resverlogix Corp. has announced findings from the recent analysis of Major Adverse Cardiovascular Events (MACE) data in patients with diabetes mellitus (DM) enrolled in both the ASSURE and SUSTAIN ...
We are initiating coverage of Resverlogix Corp. (RVX.TO) (RVXCF) with a "Hold" rating and a $3.25 price target. Resverlogix Corp. is a clinical stage cardiovascular company with an epigenetic platform ...
January 20, 2011 (Cleveland, Ohio) — Larger long-term studies may be able to show that that RVX-208, the first oral agent for raising high-density-lipoprotein cholesterol (HDL-C) through ...
AMSTERDAM, The Netherlands—A new oral agent known as RVX-208 has failed to induce more than a trend toward plaque regression compared with placebo at 6-month follow-up. Findings from the ASSURE study ...
Our first exposure to the Klipsch RVX-54 Home Theater Speaker System came while touring the sea of electronics on the convention floor at the 2005 Consumer Electronics Show (CES) in Las Vegas. In a ...
Provider of software and technology for the reverse mortgage industry, ReverseVision announced yesterday that it has completed an integration with the program, ServiceLink Flood, from the national ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results